Larvol Veri

BIOMARKER:

AXL expression

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

AXL expression AXL expression	Non Small Cell Lung Cancer NSCLC	pembrolizumab + BGB324 Sensitive: C2 – Inclusion Criteria pembrolizumab + BGB324 Sensitive : C2
AXL expression AXL expression	Colorectal Cancer CRC	cetuximab Resistant: C3 – Early Trials cetuximab Resistant : C3
AXL expression AXL expression	Melanoma Melanoma	ipilimumab Resistant: C3 – Early Trials ipilimumab Resistant : C3
AXL expression AXL expression	Renal Cell Carcinoma RCC	nivolumab Resistant: C3 – Early Trials nivolumab Resistant : C3
AXL expression AXL expression	Non Small Cell Lung Cancer NSCLC	gefitinib Sensitive: C3 – Early Trials gefitinib Sensitive : C3